126 related articles for article (PubMed ID: 7889515)
21. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray.
Ammerlaan AC; de Bustos C; Ararou A; Buckley PG; Mantripragada KK; Verstegen MJ; Hulsebos TJ; Dumanski JP
Genes Chromosomes Cancer; 2005 Aug; 43(4):329-38. PubMed ID: 15880457
[TBL] [Abstract][Full Text] [Related]
22. Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas.
Zheng PP; Pang JC; Hui AB; Ng HK
Cancer Genet Cytogenet; 2000 Oct; 122(1):18-25. PubMed ID: 11104027
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
24. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
[TBL] [Abstract][Full Text] [Related]
25. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.
Ward S; Harding B; Wilkins P; Harkness W; Hayward R; Darling JL; Thomas DG; Warr T
Genes Chromosomes Cancer; 2001 Sep; 32(1):59-66. PubMed ID: 11477662
[TBL] [Abstract][Full Text] [Related]
26. Chromosomes in the genesis and progression of ependymomas.
Rogatto SR; Casartelli C; Rainho CA; Barbieri-Neto J
Cancer Genet Cytogenet; 1993 Sep; 69(2):146-52. PubMed ID: 8402555
[TBL] [Abstract][Full Text] [Related]
27. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
Carter M; Nicholson J; Ross F; Crolla J; Allibone R; Balaji V; Perry R; Walker D; Gilbertson R; Ellison DW
Br J Cancer; 2002 Mar; 86(6):929-39. PubMed ID: 11953826
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic findings in a supratentorial ependymoma.
Dal Cin P; Sandberg AA
Cancer Genet Cytogenet; 1988 Feb; 30(2):289-93. PubMed ID: 3342386
[TBL] [Abstract][Full Text] [Related]
29. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal composition of a series of 22 human low-grade gliomas.
Rey JA; Bello MJ; de Campos JM; Kusak ME; Moreno S
Cancer Genet Cytogenet; 1987 Dec; 29(2):223-37. PubMed ID: 3677044
[TBL] [Abstract][Full Text] [Related]
31. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).
Kilday JP; Mitra B; Domerg C; Ward J; Andreiuolo F; Osteso-Ibanez T; Mauguen A; Varlet P; Le Deley MC; Lowe J; Ellison DW; Gilbertson RJ; Coyle B; Grill J; Grundy RG
Clin Cancer Res; 2012 Apr; 18(7):2001-11. PubMed ID: 22338015
[TBL] [Abstract][Full Text] [Related]
32. Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization.
Santi M; Quezado M; Ronchetti R; Rushing EJ
J Neurooncol; 2005 Mar; 72(1):25-8. PubMed ID: 15803371
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetics of pediatric central nervous system tumors.
Sainati L; Bolcato S; Montaldi A; Celli P; Stella M; Leszl A; Silvestro L; Perilongo G; Cordero di Montezemolo L; Basso G
Cancer Genet Cytogenet; 1996 Oct; 91(1):13-27. PubMed ID: 8908162
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
35. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
[TBL] [Abstract][Full Text] [Related]
36. Karyotypes in 90 human gliomas.
Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
[TBL] [Abstract][Full Text] [Related]
37. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas.
Slavc I; MacCollin MM; Dunn M; Jones S; Sutton L; Gusella JF; Biegel JA
Int J Cancer; 1995 Aug; 64(4):243-7. PubMed ID: 7657387
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
39. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells.
Nijssen PC; Deprez RH; Tijssen CC; Hagemeijer A; Arnoldus EP; Teepen JL; Holl R; Niermeyer MF
J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1245-8. PubMed ID: 7931388
[TBL] [Abstract][Full Text] [Related]
40. Molecular staging of intracranial ependymoma in children and adults.
Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
